Ticuta Negreanu-Pirjol | Pharmacology | Best Researcher Award

Prof. Dr. Ticuta Negreanu-Pirjol | Pharmacology | Best Researcher Award

Head of General and Inorganic Chemistry Discipline at Ovidius University of Constanta, Faculty of Pharmacy, Pharmaceuticals Sciences Department No. 1, Romania

Ticuta Negreanu-Pirjol, a Full Professor at the University Ovidius of Constanta, Romania, is a distinguished academic and researcher specializing in General and Inorganic Chemistry. With decades of experience in teaching, research, and administrative roles, she has played a pivotal role in shaping the academic and research landscape in Romania. Her extensive teaching portfolio includes managing courses across Pharmacy, Pharmacy Assistance, Medical Cosmetics, and Parapharmaceuticals, showcasing her versatility and dedication to education. Ticuta has also significantly contributed to the pharmaceutical industry as a Head Pharmacist. Her active involvement in professional training programs reflects her commitment to lifelong learning and advancement in her field.

Professional Profile

Education

Ticuta’s academic journey reflects a consistent pursuit of excellence. She earned her Ph.D. in Chemistry from the Polytechnic University of Bucharest in 2005, specializing in Inorganic and Coordinative Chemistry. Prior to that, she completed a Bachelor’s in Pharmacy at the Carol Davila University of Medicine and Pharmacy and a Chemical Engineering degree at the Gheorghe Asachi Polytechnic Institute. Ticuta further advanced her expertise through a Master’s in Health Services Management from the University Ovidius of Constanta. These achievements underline her interdisciplinary expertise, integrating pharmacy, chemistry, and management to excel in both academia and industry.

Professional Experience

Ticuta Negreanu-Pirjol has a robust professional background spanning over three decades. She began her career as a Chemical Engineer before transitioning to academia, where she served as a Lecturer, Associate Professor, and later as a Full Professor at the University Ovidius of Constanta. In these roles, she has headed multiple disciplines, organized courses, and developed curricula in General and Inorganic Chemistry and related fields. Additionally, Ticuta held the position of Head Pharmacist at Eurosantal Pharmacy, bridging the gap between academic research and practical applications. Her administrative expertise is evident in her leadership roles within the university, contributing to the development of academic programs and fostering research initiatives.

Research Interests

Ticuta’s research interests lie at the intersection of inorganic chemistry, pharmaceutical sciences, and biological processes. Her doctoral work focused on the complex combinations of transition metals in biological systems, a topic with significant implications in medical and pharmaceutical research. She has also explored parapharmaceuticals, cosmetic products, and technical-medical products, demonstrating a keen interest in applied chemistry. Through her work, Ticuta aims to contribute to advancements in healthcare and product innovation, ensuring that her research addresses real-world challenges.

Research Skills

Ticuta possesses a broad range of research skills, including expertise in chemical synthesis, analysis, and characterization. She is proficient in utilizing advanced tools and methodologies in inorganic and coordinative chemistry. Her skills extend to data analysis, academic writing, and project management, which are critical for successful research outcomes. Furthermore, her active participation in Web of Science training programs and research ethics courses highlights her commitment to staying updated with the latest trends and best practices in research.

Awards and Honors

Throughout her career, Ticuta has been recognized for her contributions to academia and research. Her achievements include a professional certification as a pharmacist and numerous certifications in advanced research methodologies. She has received accolades for her dedication to teaching and her ability to inspire the next generation of scientists. Her involvement in national and international training programs further highlights her standing as a respected figure in the academic and scientific community.

Conclusion

Ticuta Negreanu-Pirjol is a distinguished academic whose contributions to education, research, and professional development have left a lasting impact. Her extensive academic qualifications, diverse professional experience, and dedication to research make her a strong candidate for any prestigious award. She exemplifies the qualities of a researcher committed to innovation and excellence, with a focus on addressing contemporary challenges in science and healthcare. Her career is a testament to her passion for lifelong learning, mentorship, and advancing knowledge in her field.

Publication Top Notes

  1. Title: Aquatic plants used for heavy metals phytoaccumulation and phytoremediation potential: A review
    Authors: Negreanu-Pirjol, B.-S., Popovidu, D.R., Negreanu-Pirjol, T.
    Year: 2024
    Citations: 0
  2. Title: The Chemical Profile, Antioxidant, and Anti-Lipid Droplet Activity of Fluid Extracts from Romanian Cultivars of Haskap Berries, Bitter Cherries, and Red Grape Pomace for the Management of Liver Steatosis
    Authors: Craciunescu, O., Seciu-Grama, A.-M., Mihai, E., Ranca, A., Negreanu-Pirjol, B.-S.
    Year: 2023
    Citations: 4
  3. Title: Natural Bio-Compounds from Ganoderma lucidum and Their Beneficial Biological Actions for Anticancer Application: A Review
    Authors: Cadar, E., Negreanu-Pirjol, T., Pascale, C., Tomescu, C.L., Ionescu, A.-M.
    Year: 2023
    Citations: 11
  4. Title: Biocompounds from Green Algae of Romanian Black Sea Coast as Potential Nutraceuticals
    Authors: Cadar, E., Negreanu-Pirjol, T., Sirbu, R., Axente, E.R., Ionescu, A.-M.
    Year: 2023
    Citations: 6
  5. Title: Health Benefits of Antioxidant Bioactive Compounds in the Fruits and Leaves of Lonicera caerulea L. and Aronia melanocarpa (Michx.) Elliot
    Authors: Negreanu-Pirjol, B.-S., Oprea, O.C., Negreanu-Pirjol, T., Cosma, M., Popoviciu, D.R.
    Year: 2023
    Citations: 28
  6. Title: In Vitro Hypoglycemic Potential, Antioxidant and Prebiotic Activity after Simulated Digestion of Combined Blueberry Pomace and Chia Seed Extracts
    Authors: Mihai, E., Negreanu-Pirjol, B.-S., Craciunescu, O., Ghenea, A.-M., Negreanu-Pirjol, T.
    Year: 2023
    Citations: 3
  7. Title: Xanthophyll pigments dietary supplements administration and retinal health in the context of increasing life expectancy trend
    Authors: Jurja, S., Negreanu-Pirjol, T., Vasile, M., Coviltir, V., Negreanu-Pirjol, B.-S.
    Year: 2023
    Citations: 0
  8. Title: Preliminary Data Regarding Bioactive Compounds and Total Antioxidant Capacity of Some Fluid Extracts of Lonicera caerulea L. Berries
    Authors: Negreanu-Pirjol, B.-S., Negreanu-Pirjol, T., Popoviciu, D.R., Motelica, L., Vasile, M.
    Year: 2023
    Citations: 2
  9. Title: Marine Bioactive Compounds Derived from Macroalgae as New Potential Players in Drug Delivery Systems: A Review
    Authors: Negreanu-Pirjol, B.-S., Negreanu-Pirjol, T., Popoviciu, D.R., Anton, R.-E., Prelipcean, A.-M.
    Year: 2022
    Citations: 19
  10. Title: Marine and Agro-Industrial By-Products Valorization Intended for Topical Formulations in Wound Healing Applications
    Authors: Prelipcean, A.-M., Iosageanu, A., Gaspar-Pintiliescu, A., Marin, M., D’Amora, U.
    Year: 2022
    Citations: 13

 

 

Mohammad Hossein Boskabady | Pharmacology | Best Researcher Award

Dr. Mohammad Hossein Boskabady | Pharmacology | Best Researcher Award

Professor of Clinical Physiology, Mashhad University of Medical Sciences, Iran

Dr. Mohammad Hossein Boskabady is a distinguished researcher in the field of Pharmacology, renowned for his innovative contributions and groundbreaking research. With a strong background in pharmacological sciences, Dr. Boskabady’s work focuses on exploring the therapeutic potentials and mechanisms of various compounds. His extensive research has significantly advanced the understanding of drug actions and interactions, earning him recognition as a leading figure in pharmacological research. Dr. Boskabady’s commitment to scientific excellence and his impactful discoveries make him a deserving candidate for the Best Researcher Award.

Profile

Education 

Dr. Mohammad Hossein Boskabady’s academic journey began with his primary education in Boskabad, Khorasan, followed by high school in Gonabad, Khorasan, Iran. He earned his M.D. from Mashhad University of Medical Sciences. Dr. Boskabady furthered his studies as a postgraduate student in Physiology at University College London before completing his Ph.D. in Medicine at Charing Cross and Westminster Medical School, where he focused his thesis on the responsiveness of human bronchi to pharmacological agonists and antagonists. With a strong commitment to advancing pharmacological research, Dr. Boskabady aims to continue his research and lecturing at the university level, contributing to the field through innovative studies and academic excellence.

Employment

Dr. Mohammad Hossein Boskabady’s professional career began as a Doctor in the Emergency and Casualty Department at Imam Reza Hospital in Mashhad, Iran. Concurrently, he served as a Lecturer in Clinical Physiology at Ghaem Medical Centre, Mashhad University of Medical Sciences. Over the years, Dr. Boskabady advanced through academic ranks, holding positions as Assistant Professor, Associate Professor, and ultimately Professor in Clinical Physiology at the same institution. His extensive experience in both clinical practice and academic teaching underscores his significant contributions to the field of pharmacology and clinical physiology.

Awards

Dr. Mohammad Hossein Boskabady has been recognized for his outstanding contributions to research in Basic Medical Sciences with numerous prestigious awards. From 2000 to 2005, he won First Prizes at the Mashhad University of Medical Sciences Festival every year, and also received Second Prizes at the Razi National Festival in 2002 and 2006. He was honored as a Selected Researcher in Basic Medical Sciences for Khorasan Province in 2007 and 2008. Dr. Boskabady continued to excel, securing First Prizes at the Mashhad University of Medical Sciences Festival from 2009 to 2011, and was awarded Best Researcher at the same festival in 2012, 2013, 2016, and 2019. In 2021, he was recognized as a Selected Researcher at the School of Medicine, Mashhad University of Medical Sciences. Additionally, in November 2017, he was distinguished as a 1% world scientist by Essential Science Indicators (ESI), highlighting his global impact in the field

Official Posts

Dr. Mohammad Hossein Boskabady has held several significant roles throughout his career, reflecting his dedication and leadership in the field of medical sciences. From October 1994 to December 1996, he served as Consultant to the Vice Chancellor for Research at Mashhad University of Medical Sciences. He was a member of the Occupational Health Committee in Khorasan Province from November 1995 to October 1998 and also held the position of Director of International Affairs at Mashhad University of Medical Sciences from October 1996 to April 1999. Additionally, Dr. Boskabady was a member of the Scholarship Council from October 1997 to April 1999. He led the Physiology Department as Head from February 2000 to April 2002. Dr. Boskabady has been a member of the Editorial Board of the Journal of Basic Medical Sciences since October 1995 and has been involved with the Examination Board in Physiology for the Ministry of Health and Medical Education since August 2000. His other roles include serving on various research committees and councils at Mashhad University of Medical Sciences and acting as Secretary General for the 18th Congress of Iranian Physiology and Pharmacology in 2007. Since August 2011, he has been the Director of the Applied Biomedical Research Center at Mashhad University of Medical Sciences, and he has also served as Research Deputy for the School of Medicine from August 2011 to December 2013.

Publication Top Notes
  • Boskabady, M. H., & Snashall, P. D. (1992). Enhanced muscarinic receptor blockade with atropine in the asthmatic tracheobronchial tree: Evidence for increased drug delivery in asthma. American Review of Respiratory Disease, 145(5), 756-761. DOI: 10.1164/ajrccm/145.5.756.
  • Boskabady, M. H., & Snashall, P. D. (1996). Short term variation of atropine blockade in the tracheobronchial tree of asthmatic subjects. Medical Journal of the Islamic Republic of Iran, 10(3), 183-189. DOI: 10.17102/mjiri.1996.0108.
  • Boskabady, M. H., & Snashall, P. D. (1997). Enhanced histamine H1 receptor blockade with chlorpheniramine in the asthmatic tracheobronchial tree: Further evidence for increased drug delivery in asthma. Medical Journal of the Islamic Republic of Iran, 11(2), 115-122. DOI: 10.17102/mjiri.1997.0063.
  • Boskabady, M. H., & Shhabi, M. (1997). Bronchodilatory and anticholinergic effects of Nigella sativa on isolated guinea pig tracheal chains. Iranian Journal of Medical Sciences, 22(4), 127-133. DOI: 10.30476/ijms.1997.0549.
  • Boskabady, M. H., Rakhshandah, H., & Moetamedshariati, V. (1998). Bronchodilatory and anticholinergic effects of Carum copticum on isolated guinea pig tracheal chains. Medical Journal of the Islamic Republic of Iran, 11(5), 329-334. DOI: 10.17102/mjiri.1998.0134.
  • Boskabady, M. H., & Harati, M. (1998). Increased histamine H1 receptor blockade by chlorpheniramine in tracheal chains of asthmatic guinea-pigs. Medical Journal of the Islamic Republic of Iran, 12(2), 265-271. DOI: 10.17102/mjiri.1998.0089.
  • Boskabady, M. H., & Talebi, M. (1999). Bronchodilatory and anticholinergic effects of Carum carvi on isolated guinea pig tracheal chains. Medical Journal of the Islamic Republic of Iran, 12(3), 345-351. DOI: 10.17102/mjiri.1999.0154.
  • Boskabady, M. H., & Adel-Kardan, S. (1999). Increased muscarinic receptor blockade by atropine in tracheal chains of ovalbumin-sensitized guinea-pigs. Pharmacology, 58(6), 300-308. DOI: 10.1159/000029652.
  • Boskabady, M. H., & Shikhi, J. (2000). Inhibitory effect of Carum copticum on histamine (H1) receptors of isolated guinea pig tracheal chains. Journal of Ethnopharmacology, 69(2), 217-227. DOI: 10.1016/S0378-8741(99)00244-3.
  • Boskabady, M. H., & Simaei, N. (1999). Prevalence of asthma among young adults (high school students) in the city of Mashhad (north east of Iran). Iranian Journal of Medical Sciences, 24(1), 48-52. DOI: 10.30476/ijms.1999.0442.
  • Boskabady, M. H., & Snashall, P. D. (2000). Bronchial responsiveness to beta-adrenergic stimulation and enhanced beta blockade in asthma. Respirology, 5(2), 111-118. DOI: 10.1046/j.1440-1843.2000.00243.x.
  • Boskabady, M. H., & Moemeni, A. (2000). Stimulatory effect of Carum copticum on beta2 adrenoceptors of isolated guinea pig tracheal chains. Medical Journal of the Islamic Republic of Iran, 13(3), 273-278. DOI: 10.17102/mjiri.2000.0192.
  • Boskabady, M. H., Karbandy, S., & Abedinzadah, A. (2000). The effects of arterial O2 saturation and heart rate on blood pressure. Medical Journal of the Islamic Republic of Iran, 14(2), 37-41. DOI: 10.17102/mjiri.2000.0200.
  • Boskabady, M. H., & Karimian, M. (2000). Prevalence of asthma among guidance school students (aged 11-16 years) in the city of Mashhad (north east of Iran). Archives of Iranian Medicine, 3(3), 165-169. DOI: 10.30476/aim.2000.0109.
  • Boskabady, M. H., & Hosaini, M. (2000). Effect of patient education and regular PEF measurement on self-management of asthma. Iranian Journal of Allergy, Asthma, and Immunology, 1(2), 159-164. DOI: 10.30476/ijaai.2000.0111.
  • Boskabady, M. H., & Ramazani, M. (2001). Relaxant effect of Pimpinella anisum on isolated guinea pig tracheal chains and its possible mechanism(s). Journal of Ethnopharmacology, 74(1), 83-88. DOI: 10.1016/S0378-8741(00)00382-5.
  • Boskabady, M. H., Keshmiri, M., Banihashemi, B., & Anvary, K. H. (2002). Lung function values in healthy non-smoking urban adults in Iran. Respiration, 69(4), 320-326. DOI: 10.1159/000065155.
  • Boskabady, M. H., & Klahdoz, G. H. (2002). Prevalence of asthma symptoms among the adult population in the city of Mashhad (north-east of Iran). Respirology, 7(3), 267-272. DOI: 10.1046/j.1440-1843.2002.00413.x.
  • Boskabady, M. H., & Shirmohammadi, B. (2002). Effect of Nigella sativa on isolated guinea pig trachea. Archives of Iranian Medicine, 5(2), 103-107. DOI: 10.30476/aim.2002.0145.
  • Boskabady, M. H., & Shiravi, N. (2002). Inhibitory effect of Nigella sativa on histamine (H1) receptors of isolated guinea pig tracheal chains. Pharmaceutical Biology, 40(8), 596-602. DOI: 10.1076/1388-0209(200208)4008-0005.

Dr. David Haefliger | Pharmacology | Best Researcher Award

Dr. David Haefliger | Pharmacology | Best Researcher Award

Dr. David Haefliger, CHUV, Switzerland

Dr. David Haefliger is a distinguished expert in pharmacology, recognized for his groundbreaking research and contributions to the field. With a strong background in drug interactions and therapeutic efficacy, Dr. Haefliger’s work has significantly advanced the understanding of pharmacological mechanisms and their clinical applications. His research is widely published in leading journals and has been instrumental in shaping contemporary practices in pharmacology. As a recipient of the Best Researcher Award, Dr. Haefliger continues to drive innovation and excellence in his field, demonstrating an unwavering commitment to advancing medical science and improving patient outcomes.

Profile

Scoopus

Education 

Dr. David Haefliger has an extensive educational and professional background in the medical field. He earned his Bachelor’s degree in Medicine in June 2012 and his Master’s degree in Medicine in June 2015, both from the University of Lausanne, Switzerland. In addition to his foundational degrees, he completed the Swiss Board Examination in General Internal Medicine in June 2019, and he is an Advanced Cardiovascular Life Support Provider, certified in October 2016. Most recently, in 2024, Dr. Haefliger obtained a Certificate of Advanced Studies in Clinical Research from the University of Lausanne, further solidifying his expertise and commitment to advancing clinical research.

Proffesional Experience

Since February 2022, Dr. David Haefliger has been working in the Service of Clinical Pharmacology at the Department of Medicine, University Hospital Lausanne, Switzerland. Prior to this role, he served in the Service of Infectious Diseases at the University Hospital Lausanne from November 2019 to October 2021. Dr. Haefliger also gained valuable experience in the Intensive Care Unit at Fribourg Hospital from November 2018 to October 2019. His career began in Internal Medicine at Fribourg Hospital, where he worked from November 2015 to October 2018.

 

Publication Top Notes

  • Haefliger D, Chehade H, Livio F, Rodrigues-Veiga V, Diezi L, Marzolini C. Vancomycin Dosing Strategy for the Treatment of Peritonitis in a Child on Automated Peritoneal Dialysis: A First Pediatric Case Report. Semin Dial. 2024.
  • Dao K, Buettcher M, Golhen K, et al. Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use. J Clin Pharmacol. 2024.
  • Dao K, Shechtman S, Weber-Schoendorfer C, et al. Use of GLP-1 Receptor Agonists in Early Pregnancy and Reproductive Safety: A Multicentre, Observational, Prospective Cohort Study Based on the Databases of Six Teratology Information Services. BMJ Open. 2024.
  • Grütter S, Haefliger D, Wuerzner G, Yerly P, Bouchardy J, Rutz T. The Deleterious Consequences of a Nonsteroidal Anti-inflammatory Drug in an Eisenmenger Patient. CJC Pediatr Congenit Heart Dis. 2023.
  • Haefliger D, Marzolini C, Lamoth F, Pabst T, Buclin T, Livio F. Clinically Relevant Bidirectional Drug-Drug Interaction Between Midostaurin and Voriconazole. Br J Clin Pharmacol. 2023.
  • Haefliger D, Livio F. Pharmacothérapie – Nouveaux Médicaments et Vaccins Disponibles en 2022 [Pharmacotherapy: New Drugs and Vaccines in 2022]. Rev Med Suisse. 2023.
  • Desgranges F, Tadini E, Munting A, et al. Post-COVID-19 Syndrome in Outpatients: A Cohort Study. J Gen Intern Med. 2022.
  • Regina J, Papadimitriou-Olivgeris M, Burger R, et al. Epidemiology, Risk Factors, and Clinical Course of SARS-CoV-2 Infected Patients in a Swiss University Hospital: An Observational Retrospective Study. PLoS One. 2020.
  • Grandjean T, Haefliger D, Arroyo D, Cook S. Coronary Sinus Reduction for the Treatment of Refractory Angina. Cardiovasc Med. 2018.
  • Haefliger D, Chuard C. Légionellose [Legionellosis]. Rev Med Suisse. 2017.

Articles with Acknowledgments (as a member of the RegCOVID Study Group):

  • Galperine T, Choi Y, Pagani JL, et al. Temporal Changes in Fecal Microbiota of Patients Infected with COVID-19: A Longitudinal Cohort. BMC Infect Dis. 2023.
  • COVID-19 Host Genetics Initiative. Mapping the Human Genetic Architecture of COVID-19. Nature. 2021.
  • Bibert S, Guex N, Lourenco J, et al. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. Front Immunol. 2021.

Vikas Gupta | Pharmacology | Scientific Excellence Achievement Award |

Dr. Vikas Gupta | Pharmacology | Scientific Excellence Achievement Award |

Assistant Director , Baba Farid University of Health Sciences , India .

Dr. Vikas Gupta is a distinguished pharmaceutical scientist specializing in pharmacognosy and herbal drugs. With over a decade of experience in academia and research, he has made significant contributions to the field of pharmaceutical sciences, particularly in the development and quality control of herbal medicines. His career is marked by a strong academic background, diverse professional roles, innovative research, and numerous awards recognizing his excellence in the field.

Profile
Education

Dr. Gupta holds a Ph.D. in Pharmaceutical Sciences from Baba Farid University of Health Sciences, Faridkot, earned in January 2019. He completed his M. Pharmacy in Pharmacognosy from Punjabi University, Patiala, in 2008 with first-class honors, and his B. Pharmacy from Akal College of Pharmacy & Technical Education, Mastuana Sahib (Sangrur), under Punjab Technical University in 2005, also with first-class honors. His strong academic foundation is further reinforced by his high school education, where he achieved first-class marks from Spring Dales Public School, Sangrur.

Professional Experience

Currently, Dr. Vikas Gupta serves as the Assistant Director and Associate Professor at the University Centre of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, and the University Institute of Pharmaceutical Sciences and Research, Faridkot. His professional journey has included roles as a Production Supervisor at G. M. Remedies Pvt. Ltd., Lecturer at S. D. College of Pharmacy, and Senior Research Fellow at the National Institute of Ayurvedic Pharmaceutical Research. His progression through these roles demonstrates his ability to lead, teach, and conduct advanced research in pharmaceutical sciences.

 

Research Interests

Dr. Gupta’s primary research interests lie in the field of pharmacognosy, with a particular focus on herbal drugs, quality control, and chromatography. He is passionate about exploring the therapeutic potential of natural products and has dedicated his research to developing and validating herbal medicines that can meet modern healthcare standards. His work is driven by a commitment to improving the safety, efficacy, and quality of herbal drugs, ensuring they are a viable option in the pharmaceutical industry.

Research Skills

Dr. Gupta possesses a wide range of research skills, particularly in the areas of herbal drug technology and chromatography. His expertise includes the development and quality control of herbal drugs, where he employs advanced chromatographic techniques to ensure the purity and potency of these natural medicines. His technical skills are complemented by his experience in supervising and mentoring students in research, where he guides them through complex scientific inquiries and projects.

Awards and Recognition

Dr. Vikas Gupta’s contributions to pharmaceutical sciences have been widely recognized. He has received numerous awards, including the prestigious “Research Excellence Award-2022” from INSC International Publishers and the “Innovative Research Award” for his work on economic plant-based anti-anxiety drugs. He has also been honored with fellowships from the UPYA Foundation of Multidisciplinary Sciences, the Indian Association of Pharmaceutical Scientists and Technologists, and the Scholars Academic and Scientific Society. His recognition extends internationally, with awards such as the Bentham Ambassador by Bentham Science Publishers and the Bharat Gaurav Puraskar for his contributions to the field.

Conclusion

Dr. Vikas Gupta’s qualifications, extensive experience, and numerous recognitions make him a compelling candidate for the Scientific Excellence Achievement Award. His contributions to pharmacognosy, herbal drugs, and pharmaceutical sciences are significant and align well with the criteria for such an award.

Publications Top Notes

    1. 2024:
      • Topic: “Recommendations of Apex Health Bodies Remain Localized: Not in Conformity with International Implementation Policy for Urological Disorders”
      • Journal: The Lancet Regional Health – Southeast Asia
    2. 2024:
      • Topic: “Populations Using Traditional Home Remedy at Low Risk for COVID-19 Infection”
      • Journal: Current Traditional Medicine
    3. 2023:
      • Topic: “Future and Research Opportunity in Pharmaceutical Development and Quality Measures”
      • Book Chapter: Pharmaceuticals in Aquatic Environments: Remediation Technologies and Future Challenges
    4. 2023:
      • Topic: “Functional Finishing of Textile Materials Using Silver-Based Functionalized Nanoparticles: Health Perspectives”
      • Book Chapter: Antiviral and Antimicrobial Coatings Based on Functionalized Nanomaterials: Design, Applications, and Devices
    5. 2023:
      • Topic: “Bioinformatics Paradigms in Drug Discovery and Drug Development”
      • Journal: Current Topics in Medicinal Chemistry
    6. 2022:
      • Topic: “Grain Weight Predictors in Wheat and the Prospects of Their Utilization in Different Production Environments”
      • Journal: Cereal Research Communications
    7. 2022:
      • Topic: “Fast Track Development of Fisetin and Naringenin Based Economic Anti-Anxiety Drug Using Docking Tools”
      • Journal: Asian Journal of Psychiatry
    8. 2022:
      • Topic: “Ashtawarga: The Wonder Medicinal Herbs of Nature”
      • Book Chapter: Herbs, Spices and Their Roles in Nutraceuticals and Functional Foods
    9. 2022:
      • Topic: “Future Prospective of Nutraceutical and Functional Food with Herbs and Spices”
      • Book Chapter: Herbs, Spices and Their Roles in Nutraceuticals and Functional Foods
    10. 2022:
      • Topic: “Preface”
      • Editorial: New Horizons in Wheat and Barley Research: Global Trends, Breeding and Quality Enhancement

Shriyansh Srivastava | Pharmacology Award | Best Researcher Award

Mr. Shriyansh Srivastava | Pharmacology Award | Best Researcher Award

Assistant Professor at Pharmacology Award, Galgotias University, India

Mr. Shriyansh Srivastava is a dedicated professional with a strong academic background and diverse expertise in the field of pharmacology and clinical research. Currently pursuing a PhD at Delhi Pharmaceutical Sciences and Research University, he previously completed his M. Pharm at ISF College of Pharmacy, where he achieved a CGPA of 8.54. With a B. Pharm from Dr. A.P.J. Abdul Kalam Technical University and a 12th-grade education from CRTS Vidya Mandir, Mr. Srivastava’s academic journey demonstrates his commitment to excellence. In addition to his academic achievements, Mr. Srivastava has been serving as an Assistant Professor at Galgotias University since August 31, 2021, focusing on the pharmaceutical field. He has attended various workshops and conferences, showcasing his dedication to continuous learning and professional development. His expertise includes operating advanced laboratory equipment such as the Langendroff Apparatus, fluorescent microscope, and centrifuge. He is also skilled in animal handling, histological studies, and using MS Office applications.

Professional Profiles:

Education:

Mr. Shriyansh Srivastava is currently pursuing a PhD in Pharmacology & Clinical Research at Delhi Pharmaceutical Sciences and Research University, New Delhi, India, from 2022 to the present. He completed his M. Pharm (Pharmacology) at ISF College of Pharmacy, Moga, Punjab, India, from 2019 to 2021, with a CGPA of 8.54. His B. Pharm was completed at Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India, from 2014 to 2018, with a percentage of 74.82%. In 2013-2014, he completed his 12th grade at CRTS Vidya Mandir, Siswa, Maharajganj, Uttar Pradesh, India, with a percentage of 86.6%.

Professional Experience:

This information describes Mr. Shriyansh Srivastava’s current professional role as an Assistant Professor at Galgotias University. It specifies that he is part of the School of Medical and Allied Sciences, specifically in the Department of Pharmacy. The details include his start date, which is August 31, 2021, indicating the duration of his employment in this position. It also mentions his focus area, highlighting that his teaching and research activities are centered around the pharmaceutical field. Overall, this information provides an overview of his current professional responsibilities and academic focus within the university setting.

Award Participated:

Mr. Shriyansh Srivastava has actively participated in various workshops and conferences to enhance his professional knowledge and skills. He attended a workshop on advanced histopathological techniques using microtome, cryostat, and tissue processor in February 2021. He also presented at the International Conference on “Unlocking Challenges Innovations and Global Opportunities in Research Amidst COVID-19 Pandemic” in December 2020. Additionally, he participated in the 59th National Pharmacy Week 2020 organized by ISF College of Pharmacy, Moga, and attended a one-day international workshop on lung injury therapy in November 2019. He also participated in the 54th IHPA National conference on safe and effective medicine in September 2019 and the 31st Annual Conference of India Pharmacy Graduates Association in April 2017, showcasing his commitment to professional development and staying updated with the latest advancements in the field.

Skills:

Mr. Shriyansh Srivastava possesses a wide range of expertise in laboratory equipment and techniques. He is proficient in operating the Langendroff Apparatus, fluorescent microscope, centrifuge, non-invasive blood pressure apparatus, Eddy’s hot plate, plethysmometer, actophotometer, student organ bath, microtome, and cryostat. He also has experience in handling animals, particularly rats, mice, and guinea pigs. Additionally, he has a strong understanding of histological studies and is skilled in using MS Office applications (Word, Excel, PowerPoint). He is well-versed in safety requirements and laboratory management, ensuring a clean and safe workplace. Furthermore, he is knowledgeable about Windows operating systems and various application software such as ChemDraw, EndNote, and BioRender.

Publications:

  1. Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer management
    • Authors: S Srivastava, N Jayaswal, S Kumar, PK Sharma, T Behl, A Khalid, …
    • Year: 2024
    • Citations: 7
    • Journal: Cellular Signalling 113, 110932
  2. The Global Monkeypox (Mpox) outbreak: a comprehensive review
    • Authors: S Srivastava, S Kumar, S Jain, A Mohanty, N Thapa, P Poudel, K Bhusal, …
    • Year: 2023
    • Citations: 7
    • Journal: Vaccines 11 (6), 1093
  3. Biodegradable electrospun scaffolds as an emerging tool for skin wound regeneration: A comprehensive review
    • Authors: D Sharma, S Srivastava, S Kumar, PK Sharma, R Hassani, HG Dailah, …
    • Year: 2023
    • Citations: 6
    • Journal: Pharmaceuticals 16 (2), 325
  4. Wnt/β-catenin antagonist pyrvinium rescues high dose isoproterenol induced cardiotoxicity in rats: Biochemical and immunohistological evidences
    • Authors: S Srivastava, S Yadav, G Singh, SS Bajwa
    • Year: 2022
    • Citations: 6
    • Journal: Chemico-Biological Interactions 358, 109902
  5. Evolution of β-catenin-independent Wnt–GSK3–mTOR signalling in regulation of energy metabolism in isoproterenol-induced cardiotoxicity model
    • Authors: S Srivastava, N Bagang, S Yadav, S Rajput, D Sharma, A Dahiya, …
    • Year: 2021
    • Citations: 5
    • Journal: Inflammation Research 70 (7), 743-747
  6. Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
    • Authors: S Dhoundiyal, S Srivastava, S Kumar, G Singh, S Ashique, R Pal, …
    • Year: 2024
    • Citations: 3
    • Journal: European Journal of Medical Research 29 (1), 26
  7. Emergence of Marburg virus: a global perspective on fatal outbreaks and clinical challenges
    • Authors: S Srivastava, D Sharma, R Rijal, S Adhikari, P Bashyal, JJ Barboza, …
    • Year: 2023
    • Citations: 3
    • Journal: Frontiers in Microbiology 14, 1239079
  8. Platelet‐rich plasma exhibits anti‐inflammatory effect and attenuates cardiomyocyte damage by reducing NF‐κB and enhancing VEGF expression in isoproterenol induced …
    • Authors: S Yadav, S Srivastava, G Singh
    • Year: 2022
    • Citations: 3
    • Journal: Environmental Toxicology 37 (4), 936-953
  9. Recent Nipah virus outbreak in India: lessons and imperatives
    • Authors: S Srivastava, N Deb, P Roy, V Jaiswal, S Sah, Y Pandey, …
    • Year: 2023
    • Citations: 1
    • Journal: Therapeutic Advances in Infectious Disease 10, 20499361231208535
  10. Significant progress in chikungunya Control: FDA approval of Ixchiq vaccine
    • Authors: S Srivastava, S Kumar, P Satapathy, KH Jaaaim, AH Hermis, R Mehta, …
    • Year: 2024
    • Journal: Clinical Infection in Practice, 100351